Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

TSX:CVE
TSX:CVEOil and Gas

Is FERC’s Second Subpoena Reframing Cenovus Energy’s (TSX:CVE) Market Power And Governance Narrative?

On March 16, 2026, the U.S. Federal Energy Regulatory Commission granted Pembina Cochin LLC a second subpoena compelling Cenovus Energy to provide documents and information for a market power hearing involving its U.S. subsidiary. This enforcement step pulls Cenovus’s parent entity directly into a U.S. regulatory proceeding, potentially exposing more of its commercial arrangements and governance controls to scrutiny. We’ll now examine how FERC’s second subpoena and the related market power...
NYSE:HPQ
NYSE:HPQTech

Does HPQ’s New AI-First PCs Hint At A Deeper Shift In Its Competitive Moat?

Earlier this week, HP Inc. unveiled a broad slate of AI-powered PCs, security innovations, printers, and workflow tools aimed at reducing workplace friction and strengthening device protection across its commercial and consumer ecosystems. A distinctive element is HP IQ and its NearSense connectivity layer, which use on-device AI and proximity awareness to turn PCs, printers, and conferencing gear into a more cohesive, context-aware workplace platform. Next, we’ll examine how HP’s push into...
NasdaqGS:GTLB
NasdaqGS:GTLBSoftware

Assessing GitLab (GTLB) Valuation After GitLab 18.10 Agentic AI Release

GitLab (GTLB) has drawn fresh attention after releasing GitLab 18.10, a product update centered on agentic AI features that could shape how investors think about its role in DevSecOps platforms. See our latest analysis for GitLab. Despite the AI-focused product launch and recent conference appearance, GitLab’s share price return has weakened, with a 30 day share price return of 21.64% and a year to date share price return of 43.75% at a last close of US$20.35. At the same time, the 1 year...
SWX:AMRZ
SWX:AMRZBasic Materials

Assessing Whether Amrize (SWX:AMRZ) Looks Undervalued After Its Recent Share Price Pullback

Why Amrize Stock Is On Investors’ Radar Amrize (SWX:AMRZ) has drawn fresh attention after a recent share price pullback, with the stock showing a 12.7% decline over the past month and a 1.1% slip over the past 3 months. See our latest analysis for Amrize. The recent 12.7% 1 month share price return decline comes after a relatively mild 2.7% negative share price return year to date. This suggests that momentum has cooled rather than strengthened in the short term. If this pullback has you...
TSX:TKO
TSX:TKOMetals and Mining

A Look At Taseko Mines (TSX:TKO) Valuation As Florence Copper Ramps Up Production

Taseko Mines (TSX:TKO) is ramping up production at its Florence copper project in Arizona after reporting first metal this month, drawing renewed attention to how this new asset could influence the stock’s appeal. See our latest analysis for Taseko Mines. Taseko’s recent Florence milestone comes after a mixed share price run, with a 1-year total shareholder return of 155.08% and a very large 3-year total shareholder return. This comes even as the 30-day share price return shows a 26.90%...
NYSE:TYL
NYSE:TYLSoftware

Should Tyler Technologies’ (TYL) 2030 Targets and AI Strategy Commentary Require Action From Investors?

In recent days, analysts have highlighted Tyler Technologies ahead of its June 9 investor day and upcoming fiscal first-quarter 2026 earnings release, focusing on management’s intention to reiterate its 2030 revenue targets and discuss margins and AI’s longer-term role. An interesting thread for investors is how early-stage AI adoption and healthy software-as-a-service bookings expectations are shaping sentiment around Tyler’s long-term financial framework, even as meaningful AI-driven...
ENXTBR:HYL
ENXTBR:HYLPharmaceuticals

Hyloris Pharmaceuticals ENXTBR HYL Loss Near €3.6 Million Tests Bullish Profitability Narratives

Hyloris Pharmaceuticals FY 2025 earnings snapshot Hyloris Pharmaceuticals (ENXTBR:HYL) has opened FY 2025 with first half revenue of €3.339 million and a basic EPS loss of €0.13, setting the tone for another year where growth ambitions still sit alongside negative earnings. The company has seen revenue move from €4.64 million in the first half of 2024 to €5.12 million in the second half of 2024, with basic EPS losses of €0.12 and roughly €0.11 per share across those periods. This frames a...
NYSE:BKSY
NYSE:BKSYProfessional Services

A Look At BlackSky Technology (BKSY) Valuation After New Seven Figure Gen 3 Contract Extension

BlackSky Technology (BKSY) recently secured a seven-figure Assured extension contract with an international customer, highlighting continued use of its Gen-3 satellite imagery, AI-enabled analytics, and dual-generation tip-and-cue architecture. See our latest analysis for BlackSky Technology. The new contract arrives after a sharp 17.24% 1 day share price decline and a 10.73% 7 day share price return. However, the 30 day and 90 day share price returns of 15.35% and 20.61%, together with a 1...
ENXTPA:AKE
ENXTPA:AKEChemicals

Assessing Arkema (ENXTPA:AKE) Valuation After Recent Share Price Volatility

Recent performance snapshot for Arkema Arkema (ENXTPA:AKE) has drawn fresh attention after a mixed run for shareholders, with the stock showing a 4.5% gain over the past day but a 14.2% decline over the past year. Over the past week the share price return is 15.2%, while the past month shows a 3.4% decline and the past 3 months a 14.1% gain, leaving year-to-date performance at 11.2%. See our latest analysis for Arkema. With the share price at €58.2, Arkema has seen strong short term share...
NYSE:JBS
NYSE:JBSFood

JBS Index Removal Puts Focus On Valuation Momentum And Dividend Risks

JBS (NYSE:JBS) has been removed from the FTSE All-World Index. The change affects the company’s presence in a major global equity benchmark tracked by many passive funds. The decision may influence how both current and prospective shareholders assess JBS within global portfolios. JBS, trading at $17.03, has seen a return of 19.5% over the past week and 20.1% year to date, with a 3.8% return over the past 30 days. With a value score of 6, the stock sits in a segment of the market that some...
TASE:IMCO
TASE:IMCOAerospace & Defense

IMCO Industries (TASE:IMCO) Margin Improvement Challenges Market Skepticism In FY 2025 First Half

IMCO Industries (TASE:IMCO) has released its FY 2025 numbers with first half revenue of ₪158.5 million and basic EPS of ₪1.16, supported by trailing twelve month revenue of ₪333.5 million and EPS of ₪5.09 that reflects a 58.2% one year earnings growth on top of a 58.7% five year annualized pace. Over the past reported periods, revenue has moved from ₪128.1 million in the first half of 2024 to ₪174.9 million in the second half of 2024 and then to ₪158.5 million in the first half of 2025. EPS...
NasdaqGS:ACGL
NasdaqGS:ACGLInsurance

Is Arch Capital Group (ACGL) Still Attractive After Recent Share Price Softness?

Wondering whether Arch Capital Group at around US$93 per share still offers value, or if most of the opportunity is already reflected in the price? This article focuses squarely on what the current valuation signals might be telling you. The stock has gained 1.2% over the last 7 days, while showing a 6.0% decline over 30 days and a slight 0.5% decline year to date, alongside a 1.7% decline over the last year and longer term returns of 44.8% over 3 years and 149.3% over 5 years. Recent...
ENXTBR:SOF
ENXTBR:SOFDiversified Financial

Sofina Société Anonyme (ENXTBR:SOF) Swings To €393.9 Million Loss Challenging Margin Resilience Narrative

Sofina Société Anonyme (ENXTBR:SOF) opened FY 2025 with a weak first half, reporting a loss as basic EPS swung to €11.87 and total revenue came in at a loss of €358.9 million. This comes against a backdrop where the trailing twelve months still show positive EPS of €12.48 and revenue of €486.1 million. Over the past year, the company has seen total revenue move from €587.1 million in 2024 H1 to €844.98 million in 2024 H2 and EPS shift from €16.59 to €24.29 in the same periods, before the...
SEHK:1099
SEHK:1099Healthcare

A Look At Sinopharm Group (SEHK:1099) Valuation After The Proposed 2025 Final Dividend Announcement

Sinopharm Group (SEHK:1099) has drawn investor attention after its board proposed a final dividend of CN¥0.69 per share for 2025, totaling about CN¥2.15b, subject to approval at the June 18 AGM. See our latest analysis for Sinopharm Group. The proposed dividend comes after a period where momentum has been mixed, with a 30 day share price return showing a decline of 7.38% and a one year total shareholder return of 15.09%. This suggests recent weakness against a stronger longer term outcome. If...
NYSE:HLT
NYSE:HLTHospitality

A Look At Hilton (HLT) Valuation After Earnings And Guidance Surpassed Forecasts

Hilton Worldwide Holdings (HLT) has drawn fresh investor attention after reporting a quarter where revenue came in 3.3% above analyst expectations and EBITDA guidance for the next quarter also exceeded forecasts. Even with these earnings and guidance beats highlighting Hilton’s position within the consumer discretionary travel and vacation providers sector, the stock has moved lower since the release. This has raised questions about how the market is reading the update. See our latest...
NasdaqGM:KOD
NasdaqGM:KODBiotechs

Kodiak Sciences (KOD) Is Up 66.3% After Zenkuda’s Phase 3 Win in Diabetic Retinopathy

Kodiak Sciences recently reported positive topline results from its GLOW2 Phase 3 superiority study of Zenkuda in diabetic retinopathy, where the drug significantly outperformed sham across primary and key secondary endpoints while maintaining a favorable safety profile. A particularly important insight is that Zenkuda’s efficacy appeared consistent regardless of patients’ use of GLP-1 receptor agonists, supporting its potential relevance in a real-world diabetic population and strengthening...
TSX:FOM
TSX:FOMMetals and Mining

A Look At Foran Mining’s Valuation As McIlvenna Bay Construction Nears Completion And Transmission Line Comes Online

Foran Mining (TSX:FOM) has updated investors on construction at its McIlvenna Bay project, reporting progress of about 91% and confirming the site remains on schedule and within budget as commissioning continues. See our latest analysis for Foran Mining. At a share price of CA$5.34, Foran Mining has seen a 2.69% 1 day share price return and a 5.74% 7 day share price return. However, the 30 day share price return shows a 23.71% decline, which contrasts with a 43.55% 1 year total shareholder...
NYSE:CL
NYSE:CLHousehold Products

Is Colgate Palmolive (CL) Offering Value After Recent Share Price Weakness?

If you are wondering whether Colgate-Palmolive at around US$84.29 is offering fair value or hiding a discount, this breakdown is designed to help you frame that question clearly. The share price has slipped around 1.0% over the last week and 12.8% over the last month, even though the year to date return is 8.5% and the 1 year return sits at 7.0% in decline, with 3 year and 5 year returns of 20.4% and 20.8% respectively. Recent attention on Colgate-Palmolive has centered on how the stock fits...
NYSE:DEC
NYSE:DECOil and Gas

A Look At Diversified Energy’s Valuation After Its Recent Share Price Rebound

Recent performance snapshot Diversified Energy (DEC) has attracted fresh attention after a strong recent share price move, with the stock showing double digit gains over the past week, month and past 3 months. See our latest analysis for Diversified Energy. The recent surge in DEC's share price, with a 39.05% 1 month share price return and 22.70% year to date share price return, sits against a 44.68% 1 year total shareholder return but weaker 3 and 5 year total shareholder returns. This...
NYSE:HIG
NYSE:HIGInsurance

Hartford’s Standout Earnings Beat And Revenue Growth Might Change The Case For Investing In HIG

Earlier this week, Hartford Insurance Group reported a very strong quarter, with revenue rising 6.7% year on year and results significantly ahead of analyst expectations compared with peers. What stands out is that Hartford delivered the biggest analyst estimate beat among its sector group, underscoring how its recent performance contrasts with many competitors. Now we’ll explore how this strong revenue growth and earnings beat may influence Hartford’s existing investment narrative and key...
TSX:ELD
TSX:ELDMetals and Mining

Shareholder Revolt Tests Eldorado Gold’s Foran Deal And Capital Choices

Eldorado Gold (TSX:ELD) faces escalating shareholder opposition to its proposed $3.8b acquisition of Foran Mining Corporation. Proxy adviser Glass Lewis has recommended investors vote against the transaction ahead of the upcoming shareholder meeting. L1 Capital, an influential shareholder, has publicly criticized the deal as value destructive and plans to vote against it. Eldorado Gold, a mid tier gold producer, is seeking to expand its footprint through the proposed Foran Mining...
NYSE:CB
NYSE:CBInsurance

Chubb Reshapes Overseas General Leadership For EMEA And APAC Growth

Chubb (NYSE:CB) has appointed Ben McGregor as Head of Commercial Property for EMEA and APAC within its Overseas General division. Alex Forman has been named Head of Commercial Casualty for EMEA and APAC, also within Overseas General. Both executives will oversee key international commercial insurance lines outside North America. For you as an investor, these moves sit at the heart of Chubb’s international commercial property and casualty franchise. EMEA and APAC are major hubs for corporate...
ENXTBR:EXM
ENXTBR:EXMOil and Gas

Exmar (ENXTBR:EXM) One Off Gain Driven 56.2% Margin Challenges Earnings Quality Narratives

Exmar (ENXTBR:EXM) has just posted its FY 2025 first half numbers, with revenue of US$122.4 million and EPS of US$0.77 setting the tone for its latest earnings update. The company has seen recent revenue move from US$194.1 million in 1H 2024 to US$154.8 million in 2H 2024 and EPS shift from US$1.21 to US$1.94 over the same periods. This gives investors a clear data trail to weigh against the current print. With trailing twelve month EPS of US$2.71 and a reported net profit margin of 56.2%,...